Contratos
-
Study of the possible synergistic potentiations between the antihyperalgesic responses induced by the oral administration of PL265 abd drugs that inhibit Nav1.7 channels, FAAH inhibitores or CB1 agonists in a model of bone cancer-induced pain in mice. [FUO-EM-206-15]
Organismo: PHARMALEADS
- Fecha de Inicio:
- 10 de Junio de 2015
- Fecha de Fin:
- 10 de Diciembre de 2015
- Investigador responsable:
-
- Ana Baamonde Arbaiza
- Participantes:
-
- Lorena Suárez García